In addition, Wadi et al., reported that higher GBP1 gene expression, detected by microarray technology, correlated with poorer progression-free survival, in a set of ovarian cancer patients with optimal tumor debulking and treated with platinum + taxol chemotherapy [52]. Here, GBP1 is linked to ovarian carcinoma.